Compare IPOs Side by Side

Select 2 or 3 IPOs to compare their GMP, subscription status, financials, and more.

Select IPO...
Select IPO...
Select IPO...
Pick at least 2 IPOs to compare.
Stronger within this comparison
Add one more IPO above to see a side-by-side comparison.
GMP
+63.8%
Subscribed
459.17x
Retail odds
~0%
Very Strong Signals
Score 80/100
Parameter
Price Band ₹120 – ₹127
Lot Size 1,000 shares
Min Investment ₹2,54,000
2,000 shares (2 lots)
Issue Size ₹45.11 Cr
Fresh vs OFS Fresh 100% · OFS 0%
GMP +₹81
GMP % +63.8%
Expected Listing ₹208
GMP Trend
+39.4% → +63.8% · 7 days
Total Subscription 459.17x
QIB 299.60x
NII / HNI 699.92x
Retail 446.90x
Subscription by Day
Retail Allotment Odds ~0%
Industry P/E 42.0x
Revenue Trend
Revenue (latest FY) ₹81.0 Cr 2026
Profit after Tax (latest FY) ₹11.9 Cr
Revenue Growth +47.0%
Profit Margin 14.7%
EBITDA Margin 21.7%
ROE 61.6%
ROCE 37.3%
Debt / Equity 1.15
Signal Reading Very Strong Signals
Composite Score 80 / 100
GMP Score
75
Subscription Score
90
Financial Health Score
71
Quota Split QIB 50% · NII 15% · Retail 35%
Face Value ₹10
Lead Manager Hem Securities Ltd.
Registrar MUFG Intime India Pvt. Ltd.
Stage Listed
Open Date 04 Sept 2026
Close Date 08 Sept 2026
Allotment Date 09 Sept 2026
Listing Date 11 Sept 2026
Listing Price ₹224.90
Listing Gain +77.1%
Current Price ₹188.50
as of 16 Oct, 3:29 pm IST
Gain vs Issue Price +48.4%
Type SME
Exchange NSE SME
Price & Issue
Price Band
₹120 – ₹127
Lot Size Shares in one market lot
1,000 shares
Min Investment Smallest retail application at the upper price band (SME issues: 2 lots minimum)
₹2,54,000
2,000 shares (2 lots)
Issue Size
₹45.11 Cr
Fresh vs OFS Fresh issue raises money for the company; OFS (offer for sale) pays existing shareholders
Fresh 100% · OFS 0%
Demand: GMP & Subscription
GMP
+₹81
GMP % GMP as % of issue price — comparable across price levels
+63.8%
Expected Listing Issue price + latest GMP; grey-market indication, not a forecast
₹208
GMP Trend Daily GMP readings, oldest to latest
+39.4% → +63.8% · 7 days
Total Subscription
459.17x
QIB Qualified institutional buyers
299.60x
NII / HNI
699.92x
Retail
446.90x
Subscription by Day
Retail Allotment Odds Estimated chance per retail application, from retail subscription. Higher means easier to get shares.
~0%
Valuation
Industry P/E Average of the listed peers named in the prospectus
42.0x
Fundamentals
Revenue Trend ₹ crore per reported period
Revenue (latest FY)
₹81.0 Cr 2026
Profit after Tax (latest FY)
₹11.9 Cr
Revenue Growth Last two full financial years; part-year periods excluded
+47.0%
Profit Margin
14.7%
EBITDA Margin
21.7%
ROE Return on equity
61.6%
ROCE Return on capital employed
37.3%
Debt / Equity
1.15
Data Signals
Signal Reading
Very Strong Signals
Composite Score 0–100, combining the four components below
80 / 100
GMP Score
75
Subscription Score
90
Financial Health Score
71
Issue Structure
Quota Split Share of the issue reserved for QIB / NII / Retail
QIB 50% · NII 15% · Retail 35%
Face Value
₹10
Lead Manager
Hem Securities Ltd.
Registrar
MUFG Intime India Pvt. Ltd.
Timeline
Stage
Listed
Open Date
04 Sept 2026
Close Date
08 Sept 2026
Allotment Date
09 Sept 2026
Listing Date
11 Sept 2026
Listing & Market Price
Listing Price
₹224.90
Listing Gain
+77.1%
Current Price Exchange last-trade price, refreshed through the trading day
₹188.50
as of 16 Oct, 3:29 pm IST
Gain vs Issue Price
+48.4%
Company
Type
SME
Exchange
NSE SME

Green marks the stronger figure within this comparison only; it is a data reading, not a recommendation. GMP is an unofficial grey-market indication. Not investment advice.

How to Compare IPOs Effectively

Comparing IPOs side by side is one of the most useful exercises before applying — it forces you to look at relative valuations, growth trajectories, and demand signals rather than each issue in isolation. Use this tool to compare 2 or 3 IPOs at once across the metrics that actually move listing-day outcomes.

Which Metrics Matter Most

Not all comparison metrics are equally informative. Here's what to focus on:

  • P/E Ratio (post-issue) vs Industry P/E — a core valuation check. An IPO priced well above its listed peers generally needs faster growth or better margins to justify the premium.
  • Subscription multiple, especially QIB — institutional demand is widely watched as a sign of how professional investors view the issue. Compare QIB participation across IPOs to see where institutional interest is stronger.
  • GMP as % of issue price — absolute GMP can mislead because issue prices differ. A Rs 50 GMP on a Rs 200 issue (25%) is a stronger grey-market reading than Rs 80 on a Rs 800 issue (10%). GMP is unofficial and can change quickly.
  • Revenue growth and profit margin trends — listing-day moves are driven mostly by demand, but growth and profitability shape how the stock is valued after listing. Growth here uses full financial years only; part-year periods are excluded.
  • Issue size and OFS proportion — a high fresh-issue share means more of the money raised goes to the company, while an OFS-heavy issue mainly pays existing shareholders. Check the offer document for how the fresh capital will be used.

When Side-by-Side Comparison Helps Most

Comparison is especially useful when you have limited capital and are weighing two open IPOs, when you want to benchmark a current IPO against a recently listed peer in the same sector, or when you're comparing SME and Mainboard issues in your portfolio allocation. It is less useful for fundamentally different sectors (e.g., a tech SaaS issue vs a manufacturing issue) where direct metric comparison can mislead — there, sector context matters more.

Reading the Comparison Carefully

Avoid reading a single metric in isolation. An IPO with the highest GMP might be aggressively priced, while the one with lower GMP might have stronger fundamentals and better long-term potential. Look for IPOs that score reasonably well across multiple dimensions — valuation, fundamentals, demand, anchor quality — rather than one that maxes out a single metric. The data-signal score on each IPO's detail page already combines these; use the comparison to check or challenge that reading.

For deeper context on any individual metric, click through to each IPO's detail page from the comparison table. None of this is investment advice — always read the RHP and consult a SEBI-registered advisor before applying.

Frequently Asked Questions about Comparing IPOs

Pick two or three IPOs in the selector at the top of this page. The comparison loads as soon as two are chosen, and you can add a third, remove one, or copy a link to share the exact comparison.

Any Mainboard or SME IPO tracked on IPO Cracker, whether upcoming, open, closed or already listed. Comparing an open issue with a recently listed one in the same sector is a common way to benchmark it.

Green marks the stronger figure for that metric within the IPOs you selected, for example the higher GMP %, subscription or profit margin, or the lower P/E and debt-to-equity. It is a data reading only, not a recommendation. When the IPOs are at different stages, live figures such as GMP and subscription are shown but not ranked against final figures.

For SME IPOs, an individual investor must apply for at least two lots, and the application must be worth more than Rs 2 lakh, under the exchange rules in force since 1 July 2025. Mainboard IPOs still allow a one-lot application. The comparison shows the minimum application at the upper end of the price band.

When the retail category is oversubscribed, shares are allotted by a draw of lots, so the chance for one minimum application is roughly one divided by the retail subscription multiple. It is an estimate based on the latest subscription figure, not a guarantee. If the category is undersubscribed, every valid application receives shares.

No. The page summarises publicly available issue data, grey-market indications and our data signals. GMP is unofficial and can change quickly. Read the offer document and consult a SEBI-registered investment adviser before applying.
GMPUpdate